XPH

Innovative ETFs Channel

Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results

By Max ChenFebruary 28, 2019

Equity ETFs

With Midterms Looming, Consider Healthcare ETFs

By Brenton GarenOctober 25, 2018

Equity ETFs

ETF Plays for a Divided Midterm Elections

By Max ChenOctober 22, 2018

Equity ETFs

Pharmaceutical ETFs Could Maintain Their Momentum

By Max ChenSeptember 6, 2018

Equity ETFs

July Could Be a Volatile Month for Pharma ETFs

By Max ChenJuly 3, 2018

Equity ETFs

Get Lucky With 10 Saint Patrick’s Day ETFs

By Amiya MorettaMarch 16, 2018

Equity ETFs

Pharmaceutical ETF Surges on Healthy Outlook

By Brenton GarenMarch 12, 2018

Equity ETFs

Why Healthcare Sector is a Great November Play

By Tom LydonOctober 27, 2017

Equity ETFs

Drug Makers, Pharma ETFs Face a Tough Earnings Season

By Max ChenApril 24, 2017

Equity ETFs

Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO

By Max ChenSeptember 23, 2016

Equity ETFs

M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound

By Max ChenSeptember 12, 2016

Equity ETFs

Finding Pharmaceuticals ETFs With Rebound Potential

By Tom LydonMay 4, 2016

Equity ETFs

17 Healthcare ETFs Investors Should Check Up On

By Tom LydonApril 28, 2016

Featured

ETF Performance Report: September

By Tom LydonSeptember 30, 2015

Featured

State Street Announces Splits for 10 Industry ETFs

By Tom LydonSeptember 2, 2015

Featured

Where We Go From Here; A Little Guidance from State Street

By Tom LydonAugust 31, 2015

Featured

Pharmaceutical Sector ETF Can Maintain Its Momentum

By Tom LydonJuly 30, 2015

Featured

ETFs to Capitalize Off Obamacare Fueled Growth

By Tom LydonJuly 29, 2015